Axonis Therapeutics Announces $115 Million Series A Financing
— Oversubscribed financing brings together leading syndicate of life sciences investors — — Proceeds to support clinical development of first-in-class therapies for neurological disorders – BOSTON, Oct. 30, 2024 /PRNewswire/ — Axonis Therapeutics, a biotechnology company focused on…